2002年1月1日至2003年12月31日加拿大侵袭性脑膜炎球菌病强化监测 - Suppr

Suppr

超能文献

Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003.

出版信息

Can Commun Dis Rep. 2006 Apr 15;32(8):97-107.

PMID:16685767

Abstract

摘要

相似文献

Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003.

Can Commun Dis Rep. 2006 Apr 15;32(8):97-107.

Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.

Can Commun Dis Rep. 2007 Jun 1;33(10):1-15.

Invasive meningococcal disease in Canada, 1 January 1997 to 31 December 1998.

Can Commun Dis Rep. 2000 Nov 1;26(21):177-82.

Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 1999, through 31 December, 2001.

Can Commun Dis Rep. 2004 Feb 1;30(3):17-28.

Meningococcal infections in Quebec--1991-92.

Can Commun Dis Rep. 1992 Aug 14;18(15):113-6.

Meningococcal disease in Canada. Surveillance summary to 1987.

Can Dis Wkly Rep. 1989 Apr 29;15(17):89-96.

The changing epidemiology of meningococcal disease in the United States, 1992-1996.

J Infect Dis. 1999 Dec;180(6):1894-901. doi: 10.1086/315158.

Annual report of the Australian Meningococcal Surveillance Programme, 1998. The Australian Meningococcal Surveillance Programme.

Commun Dis Intell. 1999 Nov 25;23(12):317-23.

The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.

Pediatr Infect Dis J. 2009 Mar;28(3):220-4. doi: 10.1097/INF.0b013e31819040e7.

Meningococcal disease in Canada: surveillance summary to 1987.

CMAJ. 1989 Sep 15;141(6):567-9.

引用本文的文献

Increase in ST-11 serogroup W invasive meningococcal disease in Canada, 2016-2018.

Can Commun Dis Rep. 2019 Jun 6;45(6):164-169. doi: 10.14745/ccdr.v45i06a04.

Enhanced surveillance of invasive meningococcal disease in Canada, 2006-2011.

Can Commun Dis Rep. 2014 May 1;40(9):160-169. doi: 10.14745/ccdr.v40i09a01.

Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada.

PLoS One. 2017 May 4;12(5):e0175721. doi: 10.1371/journal.pone.0175721. eCollection 2017.

Characterization of invasive Neisseria meningitidis from Atlantic Canada, 2009 to 2013: With special reference to the nonpolysaccharide vaccine targets (PorA, factor H binding protein, Neisseria heparin-binding antigen and Neisseria adhesin A).

Can J Infect Dis Med Microbiol. 2015 Nov-Dec;26(6):299-304. doi: 10.1155/2015/393659.

Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: A decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type during the period from 2002 to 2009.

Can J Infect Dis Med Microbiol. 2012 Fall;23(3):e55-9. doi: 10.1155/2012/131328.

The changing epidemiology of meningococcal disease in North America 1945-2010.

Hum Vaccin Immunother. 2013 Jan;9(1):162-71. doi: 10.4161/hv.22302. Epub 2012 Oct 29.

Questions and answers on immunization.

Paediatr Child Health. 2007 Apr;12(4):317-8. doi: 10.1093/pch/12.4.317.

Impact of routine immunization using meningococcal C conjugate vaccine on invasive meningococcal disease in British Columbia.

Can J Public Health. 2008 Sep-Oct;99(5):380-2. doi: 10.1007/BF03405245.

Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada.

J Clin Microbiol. 2007 Jun;45(6):1753-8. doi: 10.1128/JCM.02134-06. Epub 2007 Apr 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验